---
title: "NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins"
ocid: "ocds-h6vhtk-044823"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044823"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-044823.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-044823.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS ENGLAND"
published: "2024-03-13"
---

# NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins

Buyer: NHS ENGLAND  
Current stage: Planning  
OCID: ocds-h6vhtk-044823

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044823)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-044823.json)

## Summary

The NHS England is planning a procurement process for a framework agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is expected to start on 1 January 2025 and last for 36 months, with possible extensions for up to a total of 48 months. The procurement aims to engage with the market before the Invitation to Tender, with market engagement documents to be available in March at a given website. The main procurement category is goods, and the total value of the agreement is £1.4 billion.

This tender by the NHS presents an opportunity for businesses in the health industry to compete for the supply contract of immunoglobulin solutions. Companies involved in the pharmaceutical, healthcare, and medical supplies sectors would be well-suited participants. The procurement process is currently at the planning stage, with future communication expected by May 28, 2024, providing businesses time to prepare for the invitation to tender and engage with the NHS England.

## Notice

This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.

### Lot Information

1-7

This market engagement relates to the NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins. The framework is anticipated to commence on 1 January 2025 for a period of 36 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Total maximum framework agreement including extension options will be no more than 48 months. The purpose of the PIN is to engage with the supply market on the procurement approach and to understand market and supplier capacities prior to the Invitation to Tender.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/008035-2024 |
| Notice type | Planning Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 13 Mar 2024 |
| Submission deadline | Not specified |
| Future notice date | 27 May 2024 |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £1,400,000,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planned |
| Lots status | Planned |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651520 - Immunoglobulins

## Release History

- 13 Mar 2024 at 13:47 - Planning - Planning Notice - https://www.find-tender.service.gov.uk/Notice/008035-2024

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://www.england.nhs.uk//

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-044823. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-044823.json.